In addition, PD models such as N-methyl-4-phenylpyridine (MPP+), 6-hydroxydopamine (6-OHDA) and rotenone decreased mTOR signaling and up-regulated apoptotic proteins [26]. This evidence concerns the gene MTOR and Parkinson disease.